Emerald Mutual Fund Advisers Trust’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
SUT
NVPX
Emerald Mutual Fund Advisers Trust's HCAT Position: Q1 2020 in Review
Emerald Mutual Fund Advisers Trust sold out of Health Catalyst (HCAT) in Q1 2020, closing a stake of 17,116 shares — an estimated $594K sold.
Emerald Mutual Fund Advisers Trust first reported a position in HCAT in Q3 2019 and held it in 2 quarters. The position peaked at $594K in Q4 2019. 108 funds tracked by Wall St. Rank hold HCAT as of Q1 2020.
- Emerald Mutual Fund Advisers Trust reported no remaining Health Catalyst position as of Q1 2020 after selling out during the quarter.
- Emerald Mutual Fund Advisers Trust sold 17,116 Health Catalyst shares in Q1 2020, an estimated $594K.
- Emerald Mutual Fund Advisers Trust first reported a position in Health Catalyst in Q3 2019 and held it in 2 quarters.
- Emerald Mutual Fund Advisers Trust's Health Catalyst position peaked at $594K in Q4 2019.
- 108 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2020.
Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q1 2020, filed 30 Apr 2020.